Cannarma, India’s pioneering Ayurvedic hemp-based products company, is set to raise USD 3 million in funding. This infusion of capital will bolster key areas including marketing, global expansion, intellectual property (IP) development, and team enhancement. With a well-established distribution network, Cannarma is prepared to scale its operations both domestically and internationally. The funding will empower the company to refine its distribution channels, ensuring its innovative products reach a broader audience. This expansion is in line with Cannarma’s mission to offer natural and effective health solutions worldwide.
Cannarma’s approach to holistic wellness combines modern science with ancient Ayurvedic practices. The company is targeting the medicinal cannabis market, which is projected to be valued at USD 19.44 billion in 2024 and is expected to grow to USD 82.27 billion by 2031, with a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031.
Keshav Agarwal, Director of Cannarma, expressed his enthusiasm about the new funding round: “Securing the funding will enable us to accelerate our growth and bring our high-quality hemp products to more markets. We are committed to drive innovation in the medicinal cannabis space and provide natural health solutions that are both effective and safe.”
Cannarma sources its raw materials locally from Himachal Pradesh, known as the “mother of all herbs.” The materials are formulated in-house and processed in a GMP facility managed by co-founder Rohit Chauhan, who has extensive experience working in cannabis plant science in Europe and India. This ensures that each product maintains its efficacy and quality.
Cannarma’s strategic direction is guided by an esteemed advisory board, which includes Mihir Kapoor, Managing Partner of IEG India, a leading European Investment Bank; Dr. Deepak Pant, a renowned expert in the field; and Prakash Khalate from Dhanwantri Distributors Pvt Ltd. Their combined expertise and insights drive Cannarma’s growth and innovation.
Advisory firm Caerus3Advisor and Think Tank are already supporting Cannarma’s global expansion. Harshil Pethani, Managing Director of Caerus3Advisor and Think Tank, stated, “Cannarma’s unique approach of combining traditional Ayurvedic wisdom with modern phytopharmaceuticals positions it as a leader in the industry. We are confident that the investment will help them achieve new heights and drive significant advancements in healthcare.”